Last updated on 13 June 2012
Sharmila joined the Association of Medical Research Charities (AMRC) as chief executive in November 2011. She has enjoyed a varied career, spanning media, technology and health. She spent 12 years at the BBC where she was most recently the Chief Operating Officer and Finance Director of BBC Future Media and Technology, managing the business functions of bbc.co.uk including the launch of the iPlayer. For the past two years she has been Executive Director of Finance and Performance for NHS Sussex.
Sharmila started her career in management consulting after graduating in physiological sciences from the University of Oxford, and worked on corporate finance and strategy projects for a range of private sector clients in media, telecoms and technology around the world.
She has held non-executive roles in the health and science sectors including: Deputy Chair of the Human Fertilisation and Embryology Authority, the body that regulates all embryo research and licences assisted reproduction clinics in the UK, and Board Member of the Human Tissue Authority which regulates the storage and use of human tissue.
Sharmila is currently in her second term as Board Member of the Charity Commission. She has also recently been appointed to the General Council of the University of Sussex and the audit committee of the Institute for Cancer Research. In addition to her non-executive work, she took a world fellowship at Yale University in 2007 where she lectured on both media policy and practical cases in medical ethics.
Paid employment, office or profession
Chief Executive, Association of Medical Research Charities
Directorships, whether paid or not
Any business, professional or public activities or interests that provides a regular source of income, recognition or some other benefit
Membership of public bodies, trusteeship of a charity or other public or private trust, or membership, role or affiliation to clubs or organisations
Member, General Council, University of Sussex
Member Audit Committee, Institute of Cancer Research
Any shareholdings other than those held by a unit trust or similar arrangements where the Board member has no influence on the management of the shares